Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning

EIDD-2801 is an orally bioavailable prodrug, which will be applied for emergency use authorization from the U.S. Food and Drug Administration for the treatment of COVID-19. To investigate the optimal parameters, EIDD-2801 was optimized via a four-step synthesis with high purity of 99.9%. The hydroxy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhen Qin, Bin Dong, Renbing Wang, Dechun Huang, Jubo Wang, Xi Feng, Jinlei Bian, Zhiyu Li
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/e311f1d537714e31bf747cecb30787ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e311f1d537714e31bf747cecb30787ef
record_format dspace
spelling oai:doaj.org-article:e311f1d537714e31bf747cecb30787ef2021-12-02T05:01:26ZPreparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning2211-383510.1016/j.apsb.2021.10.011https://doaj.org/article/e311f1d537714e31bf747cecb30787ef2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2211383521004032https://doaj.org/toc/2211-3835EIDD-2801 is an orally bioavailable prodrug, which will be applied for emergency use authorization from the U.S. Food and Drug Administration for the treatment of COVID-19. To investigate the optimal parameters, EIDD-2801 was optimized via a four-step synthesis with high purity of 99.9%. The hydroxylamination procedure was telescoped in a one-pot and the final step was precisely controlled on reagents, temperature and reaction time. Compared to the original route, the yield of the new route was enhanced from 17% to 58% without column chromatography. The optimized synthesis has been successfully determinated on a decagram scale: the first step at 200 g and the final step at 20 g. Besides, the relationship between yield and temperature, time, and reagents in the deprotection step was investigated via Shapley value explanation and machine learning approach-decision tree method. The results revealed that reagents have the greatest impact on yield estimation, followed by the temperature.Zhen QinBin DongRenbing WangDechun HuangJubo WangXi FengJinlei BianZhiyu LiElsevierarticleEIDD-2801SARS-CoV-2Antiviral drugDecision treeShapley valueTherapeutics. PharmacologyRM1-950ENActa Pharmaceutica Sinica B, Vol 11, Iss 11, Pp 3678-3682 (2021)
institution DOAJ
collection DOAJ
language EN
topic EIDD-2801
SARS-CoV-2
Antiviral drug
Decision tree
Shapley value
Therapeutics. Pharmacology
RM1-950
spellingShingle EIDD-2801
SARS-CoV-2
Antiviral drug
Decision tree
Shapley value
Therapeutics. Pharmacology
RM1-950
Zhen Qin
Bin Dong
Renbing Wang
Dechun Huang
Jubo Wang
Xi Feng
Jinlei Bian
Zhiyu Li
Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
description EIDD-2801 is an orally bioavailable prodrug, which will be applied for emergency use authorization from the U.S. Food and Drug Administration for the treatment of COVID-19. To investigate the optimal parameters, EIDD-2801 was optimized via a four-step synthesis with high purity of 99.9%. The hydroxylamination procedure was telescoped in a one-pot and the final step was precisely controlled on reagents, temperature and reaction time. Compared to the original route, the yield of the new route was enhanced from 17% to 58% without column chromatography. The optimized synthesis has been successfully determinated on a decagram scale: the first step at 200 g and the final step at 20 g. Besides, the relationship between yield and temperature, time, and reagents in the deprotection step was investigated via Shapley value explanation and machine learning approach-decision tree method. The results revealed that reagents have the greatest impact on yield estimation, followed by the temperature.
format article
author Zhen Qin
Bin Dong
Renbing Wang
Dechun Huang
Jubo Wang
Xi Feng
Jinlei Bian
Zhiyu Li
author_facet Zhen Qin
Bin Dong
Renbing Wang
Dechun Huang
Jubo Wang
Xi Feng
Jinlei Bian
Zhiyu Li
author_sort Zhen Qin
title Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
title_short Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
title_full Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
title_fullStr Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
title_full_unstemmed Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
title_sort preparing anti-sars-cov-2 agent eidd-2801 by a practical and scalable approach, and quick evaluation via machine learning
publisher Elsevier
publishDate 2021
url https://doaj.org/article/e311f1d537714e31bf747cecb30787ef
work_keys_str_mv AT zhenqin preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT bindong preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT renbingwang preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT dechunhuang preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT jubowang preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT xifeng preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT jinleibian preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
AT zhiyuli preparingantisarscov2agenteidd2801byapracticalandscalableapproachandquickevaluationviamachinelearning
_version_ 1718400862068408320